Warshauer, D M <br/><br/>
Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.  [electronic resource] 

 -  Radiology  Feb 1997 
 - 394-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0033-8419 
<br/><br/><label>Standard No.: </label>10.1148/radiology.202.2.9015064  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aortography<br/>Contrast Media--administration & dosage<br/>Diatrizoate--administration & dosage<br/>Diatrizoate Meglumine--administration & dosage<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Glucagon--administration & dosage<br/>Humans<br/>Injections, Intravenous<br/>Liver--diagnostic imaging<br/>Liver Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Portal Vein--diagnostic imaging<br/>Tomography, X-Ray Computed